scholarly journals Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)

2020 ◽  
Vol 31 (1) ◽  
pp. 67-75
Author(s):  
F. Stephen Hodi ◽  
Paul B. Chapman ◽  
Mario Sznol ◽  
Christopher D. Lao ◽  
Rene Gonzalez ◽  
...  
Keyword(s):  
North American ◽  
Advanced Melanoma ◽  
Safety And Efficacy ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

Correlation between baseline characteristics and clinical outcome of patients with pretreated advanced melanoma who received pembrolizumab (PEMBRO) in an expanded access program (EAP).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e21058-e21058
Author(s):  
Elisa A. Rozeman ◽  
Yanina Jansen ◽  
MarnixMarnix Heimen Geukes Foppen ◽  
Max Schreuer ◽  
Sofie Wilgenhof ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Advanced Melanoma ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Baseline Characteristics ◽  
Access Program

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma

2013 ◽  
Vol 36 (3) ◽  
pp. 215-222 ◽  
Author(s):  
Sofie Wilgenhof ◽  
Stephanie Du Four ◽  
Frederik Vandenbroucke ◽  
Hendrik Everaert ◽  
Isabelle Salmon ◽  
...  
Keyword(s):  
Advanced Melanoma ◽  
Single Center ◽  
Expanded Access ◽  
Single Center Experience ◽  
Expanded Access Program ◽  
Access Program

scholarly journals Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Cancer ◽  
2010 ◽  
Vol 116 (5) ◽  
pp. 1272-1280 ◽  
Author(s):  
Walter M. Stadler ◽  
Robert A. Figlin ◽  
David F. McDermott ◽  
Janice P. Dutcher ◽  
Jennifer J. Knox ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
North America ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Safety And Efficacy ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program

2017 ◽  
Vol 19 (6) ◽  
pp. 761-768 ◽  
Author(s):  
M. González-Cao ◽  
◽  
A. Arance ◽  
J. M. Piulats ◽  
I. Marquez-Rodas ◽  
...  
Keyword(s):  
Advanced Melanoma ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

scholarly journals Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program

JAMA Oncology ◽  
2019 ◽  
Vol 5 (4) ◽  
pp. 570 ◽  
Author(s):  
Noah Z. Feit ◽  
Debra A. Goldman ◽  
Evan Smith ◽  
Jenny Deighan ◽  
Alexia Iasonos ◽  
...  
Keyword(s):  
Drug Administration ◽  
Food And Drug Administration ◽  
Single Patient ◽  
Safety And Efficacy ◽  
Expanded Access ◽  
Expanded Access Program ◽  
The Us ◽  
Patient Use ◽  
Access Program
Sign in / Sign up

Export Citation Format

Share Document